Theme: Future challenges and the latest Impact Factor for Neuro-Oncology and Brain Tumor

Neuro Oncology 2019

Renowned Speakers

Neuro Oncology 2019

Conference series llc LTD invites all the participants from all over the world to attend 5th International Conference on Neuro-Oncology and Brain Tumor" (Neuro-Oncology 2019)during August 14-15, 2019 Tokyo,Japan, which includes prompt Keynote Presentations, Oral Talks, Poster Presentations, and Exhibitions.

Conference Highlights

  •     200+ Participation (70% Industry: 30% Academia)
  •     5+ Keynote Speakers
  •     50+ Plenary Speakers
  •     5+ Exhibitors
  •     10 Innovative Educational Sessions
  •     5+ Workshops
  •     B2B Meetings

Target Audience:

We are happy to bring to your notice that Conference Series llc LTD is hosting the "5th International Conference on Neuro-Oncology and Brain Tumor" (Neuro Oncology 2019) along with external scientific association with the Academicians, Directors, Laboratory researchers, Professors, Associate Professors, Professionals, Lecturers, Scientists and students, around the globe, scheduled on August 14-15, 2019 Tokyo,Japan.

  • Neurologist
  • Neuro Oncologist
  • Psychiatrist
  • Pharmaceutical company
  • Research scholars
  • Pathologist
  • Diagnostics companies
  • Neuroscience Professors
  • Neuroradiologists
  • Researchers and others
  • Academicians
  • Neuro Pharmacologists
  • Research and Development Department.
  • Laboratory Professionals
  • Ph.D. Students

Target Audience for the conference are Physicians and Allied Health Professionals in the field of:

  •         Adult Medical Oncology and Hematology
  •         Pediatric Oncology and Hematology
  •         Neuro-Oncology
  •         Neurology
  •         Neurosurgery
  •         Radiation Oncology
  •         Neuropathology and others

Who should attend?

Scientists and Researchers, Neurologist, Neuro Oncologist, Radiologist, Biotechnologists, Medical specialists, Clinicians and Chemists from Academics, Pharmaceutical/Biotechnology/Forensic/Environmental Industries, Laboratories working in the accompanying regions/field

  • Directors
  • Head of Department
  • Professors
  • Industrial Researchers
  • Neuro-oncologist
  • Radiation Oncologists
  • Oncologists
  • Neuropediatricians
  • Neurophysiologists
  • Neurosurgeons
  • Neurologist
  • Neuroradiologist
  • Neuro-Pathologists
  • Rehabilitation Specialists
  • Nurses
  • Neuroscience Researchers and Students from academia in the research of Neuro-oncology, Neurooncology Associations, Brain tumour societies

Benefits of Attending the Conference:

  • Networking Opportunities, Grow Your Professional Network
  • Build Your Knowledge Base
  • Expand Your Resources
  • Meet Experts & Influencers Face to Face
  • Learning in a New Space
  • Break Out of Your Comfort Zone
  • New Tips & Tactics
  • Greater Focus
  • Top Industries Representation
  • Abstracts will be published in the conference souvenir and respective International journals
  • Each Abstract will receive unique (DOI) Number provided by Cross Ref
  • Website visibility to more than 35K visitors in less than 6 months
  •  Laudable talks by the top-notch of the Global Scientific Community
  • The Serendipity of the Random Workshop
  • Will be felicitated with International Organizing Committee Member (IOCM)
  • Remarkable Awards and Global Recognition to meritorious Researchers

Dear Colleagues,

Conference Series extends its welcome to the conference 5th International Conference on Neuro-Oncology and Brain Tumor (Neuro Oncology 2019) during August 14-15, 2019 Tokyo,Japan with a theme “Future challenges and the latest Impact Factor for Neuro-Oncology and Brain Tumor”. Conference Series through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. Conference Series llc LTD Organizes 1000+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board members. Neuro-Oncology 2019, Conference will focus on educational research directed toward its impact on clinical outcomes, through oral and poster presentations, educational workshop sessions, and influential plenary presentations. Neuro-Oncology 2019 is a perfect platform to find out how Neuro-Oncology research innovations helpful to the Medical, Health and human society. Conference will mainly focus on the trending topics during presentations of the two-day event, which reflect current education, research, developments and innovations internationally in the field of Neuro-Oncology and medical sectors.

It is our pleasure to invite you for the conference “5th International Conference on Neuro-Oncology and Brain Tumor” going to be held during August 14-15, 2019 Tokyo,Japan. The main theme of our conference is “Future challenges and the latest Impact Factor for Neuro-Oncology and Brain Tumor “which covers wide range of critically important sessions.

Around 1 billion people, nearly one in six of the world’s population, suffer from Neurological disorders like Multiple Sclerosis, Alzheimer, Parkinson Disease, Stroke, Epilepsy, Migraine, Brain injuries and Neuro-infections.

The World Health Organization estimated that Neurological disorders affect up to one Billion people Worldwide. In fact, Neurological diseases make up 11% of the World’s disease burden, not including mental health and addiction disorders.

Track 1:  Neuro-Oncology

The Neuro oncology is denounced to various malevolent disorders. Central Nervous System covers its mechanism, Metastatic pestilence, Ramification, Cancers, Neurons and Sensory Receptors, Neurological Disorders, Neurodegenerative disease and Imaging agents to CNS neurofibroma. Cancer spreads to the Nervous System by direct invasion or compression from continuous tissues relates to the proximity of the Nervous System to other structures.

Global Central Nervous System Drugs market to grow at a CAGR of -3.2% over the period 2011-2015. The global central nervous system (CNS) therapeutics peddle has been forecast to reach US$133 billion by the year 2018, which increases in disease ubiquity rates due to increase in population, introduction of new drugs, and increased outgo on healthcare.

Relevant Conferences: Neurology Conference Neuroscience conferences | Neurology Congress Conferences in Europe28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5th World Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria, 5th International Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria, 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland, 12th Global Neurologists Meeting on Neurology and Neurosurgery, September 21-22, 2018 Singapore

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Georgian Society of Neurologists

Track 2:  Brain Tumor

Brain Tumor occurs when abnormal cells form within the brain. The symptoms of Brain stem tumors vary greatly and can include AtaxiaCranial Nerve Palsy, headaches, problems with speech and swallowing, hearing loss, weakness, Hemiparesis, vision abnormalities, ptosis, and behavioural changes. Another possible symptom is vomiting. Any brain tumor is inherently serious and life-threatening because of its invasive and infiltrative character in the limited space of the Intracranial Cavity.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: American Public Health Association | American Society for Cell Biology (ASCB) | American Society for Experimental Neuro Therapeutics (ASENT) |  American Society for Neural Transplantation & Repair |  Association for Psychological Science |  National Association for Equal Opportunity in Higher Education (NAFEO) |  Asian Society for Neuro-Oncology

Track 3:  Neoplasms

Neoplasm is an abnormal growth of tissue, which forms a mass that commonly referred to as a Tumor. Neoplasm can be caused by an Abnormal Proliferation of Tissues, that which can be caused by Genetic mutations. Not all types of Neoplasms cause a tumorous overgrowth of tissue. Malignant Neoplasms derived from epithelial cells are called Carcinomas.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: American Public Health Association | American Society for Cell Biology (ASCB) | American Society for Experimental Neuro Therapeutics (ASENT) |  American Society for Neural Transplantation & Repair |  Association for Psychological Science |  National Association for Equal Opportunity in Higher Education (NAFEO) |  Asian Society for Neuro-Oncology

Track 4:  Metastatic Cancer

Metastasis is defined as the process by which Cancer cells spread to other parts of the body. Metastatic Cancer is called as Stage IV cancer among many stages of it. Metastasis is one of the hallmarks of cancer distinguishing it from benign tumors. And it can spread to distant parts of the body.

Relevant Conferences: Neurology ConferencesNeurooncology CongressNeurology Events, Meetings on Neurology , 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam, Netherlands, Annual Congress on Neurology & Neuroscience March 14-15, 2019 Paris, France; 24th International Conference on Neurosurgery and Neuroscience March 18-20, 2019 Edinburgh, Scotland; 5th International Conference on Spine and Spinal Disorders, April 25-26, 2019 Rome, Italy; 8th International Conference on Brain Injury and Neuroscience, March 14-15, 2019 Paris, France

Related Associations and Societies: American Board of School Neuropsychology (ABSNP), American Clinical Neurophysiology Society (ACNS), American College of Neuropsychopharmacology (ACNP), American Neurological Association (ANA), Association for the Neurologically Disabled of Canada (AND Canada) - Canada (CA), Association of British Neurologists (ABN) - United Kingdom (UK), American Neuropsychiatric Association (ANPA), American Neurotology Society(ANS), Canadian Association of Neuroscience Nurses (CANN) - Canada (CA), Canadian Congress of Neurological Sciences (CCNS) - Canada (CA), American Psychological Association(APA Division 40) - Clinical Neuropsychology, American Society for Experimental NeuroTherapeutics (ASENT).

Track 5:  Meningioma

Meningioma is referred to as slow growing Brain tumors, but their origin is not from the Brain tissue. Meningiomas are often benign tumors arising from the Arachnoidal cells of Meninges of the brain and spinal cord. Meningiomas usually grow inward slowly, causing pressure on the Brain or Spinal cord. They interfere with the normal functions of the Brain after reaching a large size. They represent about one-third of all Primary Brain Tumors and occur most frequently in middle-aged women.

Relevant Conferences: Neurology Conference | Neuroscience conferences | Cancer Congress | Conferences in Europe28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5th World Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria, 5th International Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria, 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland, 12th Global Neurologists Meeting on Neurology and Neurosurgery, September 21-22, 2018 Singapore

Related Associations and Societies: American Board of School Neuropsychology (ABSNP), American Clinical Neurophysiology Society (ACNS), American College of Neuropsychopharmacology (ACNP), American Neurological Association (ANA), Association for the Neurologically Disabled of Canada (AND Canada) - Canada (CA), Association of British Neurologists (ABN) - United Kingdom (UK), American Neuropsychiatric Association (ANPA), American Neurotology Society(ANS), Canadian Association of Neuroscience Nurses (CANN) - Canada (CA), Canadian Congress of Neurological Sciences (CCNS) - Canada (CA), American Psychological Association(APA Division 40) - Clinical Neuropsychology, American Society for Experimental NeuroTherapeutics (ASENT

Track 6:  Gangliocytomas

Gangliocytomas are rare indolent CNS tumours which are made up of mature neurons arising anywhere within the Neuroaxis. They differ from gangliogliomas as they lack neoplastic glial cells. Treatment involves surgical removal of the tumor. These are Neuroepithelial Tumors which line the ventricles of the brain and produces Cerebrospinal fluid.

Relevant Conferences: Neurology Conference | Neuroscience conferences | Neurology Congress | Conferences in Europe 28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5th World Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria, 5th International Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria, 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland, 12th Global Neurologists Meeting on Neurology and Neurosurgery, September 21-22, 2018 Singapore

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Indian Society of Neuro-Oncology | Georgian Society of Neurologists

Track 7:  Choroid Plexus Tumor

Choroid Plexus Tumor arises from Brain tissue that invades nearby tissue and spread widely via the cerebrospinal fluid. Like other brain tumors, choroid plexus tumors are also “graded.” Like other Brain Tumors, Choroid Plexus Tumors are also “graded.” Choroid Plexus Neoplasms are rare, Intraventricular, Primary Central Nervous System (CNS) tumors derived from Choroid Plexus Epithelium that are seen predominantly in children.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: American Public Health Association | American Society for Cell Biology (ASCB) | American Society for Experimental Neuro Therapeutics (ASENT) |  American Society for Neural Transplantation & Repair |  Association for Psychological Science |  National Association for Equal Opportunity in Higher Education (NAFEO) |  Asian Society for Neuro-Oncology

Track 8:  Brainstem Glioma

A Brainstem glioma is an aggressive and dangerous Cancerous Glioma Tumor in the brainstem which starts in the Brain or Spinal cord tissue and typically spread throughout the Nervous System. It is more diagnosed in children and young adults under the age of twenty. Symptoms of Brainstem glioma can develop slowly and subtly and may go unnoticed for months. A sudden onset of symptoms tends to occur with more rapidly growing, high-grade tumors. In other cases, the symptoms may arise abruptly. Unlike most Brain tumors, Brainstem Glioma is not often treated with Neurosurgery due to complications in vital parts of the Brain. Without treatment, the life expectancy is typically a few months from the time of diagnosis.

Relevant Conferences: Neurology Conference | Neuroscience conferences | Cancer Congress |  28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5thWorld Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria; 5thInternational Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria; 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Australian Oncology Social Work Inc | Georgian Society of Neurologists

Track 9:  Neuropsychology and Neuropsychiatry

The Psychosocial and Neurocognitive functioning of several cancer patients and survivors deleteriously affected by various treatments of Malignant tumors such as ChemotherapyRadiotherapy and Hormonal therapy. Oncology researchers and Clinicians are increasingly Cognizant of the negative effects of Cancer and its treatments on the Brain and its mental processes and Cognitive outcomes.

Neuropsychology in Cancer features the current findings on the Neuropsychological effects of the Cancers and their treatments along with the most promising Neuropsychological and behavioural health interventions available to mitigate these deficits.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: American Public Health Association | American Society for Cell Biology (ASCB) | American Society for Experimental Neuro Therapeutics (ASENT) |  American Society for Neural Transplantation & Repair |  Association for Psychological Science |  National Association for Equal Opportunity in Higher Education (NAFEO) | SNO Society for Neuro-Oncology

Track 10:  Para Neoplastic Neurological Syndrome

Para Neoplastic Neurological Syndromes (PNS) are defined as the remote effects of cancer on the Nervous System. They are due to the presence of Cancer and exclusion of other known causes of the Neurological symptoms, but this criterion does not separate “true” PNS from Neurological syndromes that are coincidental with a Cancer.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: American Public Health Association | American Society for Cell Biology (ASCB) | American Society for Experimental Neuro Therapeutics (ASENT) |  American Society for Neural Transplantation & Repair |  Association for Psychological Science |  National Association for Equal Opportunity in Higher Education (NAFEO) | SNO Society for Neuro-Oncology

Track 11:   Novel Therapies in Neuro-Oncology

The Response Assessment in Neuro-Oncology (RANO) Working Group is an international, Multidisciplinary effort to develop new standardized response criteria for Clinical trials in Brain tumors. The Surgery Working Group of RANO identified surgically related End-point evaluation problems that were not addressed in the original Macdonald criteria. Macdonald criteria led to the initiation of an International effort in Neurooncology to develop Novel Response and Progression Assessment Criteria.

Relevant Conferences: Neurology Conference | Neuroscience conferences | Neurology Congress |  28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5thWorld Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria; 5thInternational Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria; 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | Australian Oncology Social Work Inc | Georgian Society of Neurologists

Track 12:   Advancements in Neuro-Oncology

In low-grade Gliomas, stereotactically guided conformal Radiotherapy should lead to a significant reduction in Radiation-associated late toxicity, while in selected groups of high-grade Gliomas the use of adjuvant or Neo-adjuvant Chemotherapy may improve survival. In primitive Neuroectodermal Tumours Prognostic Biological markers have been identified that are undergoing prospective evaluation. In infants the use of post-surgical chemotherapy alone may allow the postponing of Radiotherapy in selected cases. For patients with localized Medulloblastomas a new standard treatment is emerging that uses reduced-dose Craniospinal Radiotherapy followed by Platinum-based chemotherapy, while in Supratentorial primitive Neuroectodermal tumours future treatment will be aimed at improving local control.

Relevant Conferences: Neurology and Psychiatric Meetings | Neuro Oncology Conferences | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | International Dyslexia Association and International Essential Tumor Foundation | Georgian Society of Neurologists

Track 13:   Neurosurgical Oncology

Neurosurgery is a complex surgical method that presupposes treatment, diagnosis, and rehabilitation of disorders affecting any region of the Nervous System. Some of the preponderance common Neuro surgeries are skull base surgeryImage Guided SurgeryLaser SurgerySpinal Neurosurgery and Neuro surgical treatment.

The Global Neurosurgery market is expected to raise 11.71% over the session of 2014-2019. Neurosurgery session includes Image Guided Surgery, Laser Surgery, Surgical operation for brain fibro adenoma, Spinal Neurosurgery, Skull base surgery, Neuro surgical treatment, Geriatric Neurosurgery, latest innovations and techniques.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | International  Rett  Syndrome Foundation and Intracranial Hypertension Research Foundation | Georgian Society of Neurologists

Track 14:   Advancements in Brain Tumor

The upcoming implementation of a Neurosurgical ablation device that provides controlled therapy for brain lesions those are difficult to reach and treat. This tool, will allow us to introduce the probe into the tumor and destroy it without having to perform a Surgical Operation or Craniotomy.

Recent advances have made treatment for brain tumors much safer and more successful. Some of these newer techniques include:

•Antiseizure/Antiepileptic Drugs (AEDs)

•Steroids

•Surgery: The goal of surgery in the treatment of metastasis is to maximally remove tumor while leaving patients with good function

•Radiosurgery: A non-invasive technique that delivers numerous narrow, precisely aimed, highly focused beams of ionizing radiation that converge at a specific point.

•Radiation therapy: X-rays and other forms of radiation can destroy tumor cells or delay tumor   growth.

•Chemotherapy: The use of drugs to kill rapidly dividing cells. It can be taken orally or intravenously.

•Targeted therapy: The focus on a specific element of a cell, such as molecules or pathways required for cell growth, in order to use them as a target.

Relevant Conferences: Neurology Conference | Neuroscience conferences | Neurology Congress |  28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5thWorld Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria; 5thInternational Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria; 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | International  Rett  Syndrome Foundation and Intracranial Hypertension Research Foundation | Georgian Society of Neurologists

Track 15:   Brain Tumor Diagnosis

The following are the steps involved in Brain Tumor Diagnosis;

  •  A neurological exam: A neurological exam may include, among other things, checking your vision,            hearing, balance, coordination, strength and reflexes. Difficulty in one or more areas may provide clues        about the part of your brain that could be affected by a brain tumor.
  •   Imaging testsMagnetic Resonance Imaging (MRI) is commonly used to help diagnose brain tumors.           In some cases a dye may be injected through a vein in your arm during your MRI study.

   A number of specialized MRI scan components — including functional MRI, perfusion MRI and Magnetic Resonance Spectroscopy

Other imaging tests may include Computerized Tomography (CT) scan and Positron Emission Tomography (PET).

  • Tests to find cancer in other parts of your body: If it's suspected that your Brain tumor may be a result of Cancer that has spread from another area of your body, your doctor may recommend tests and procedures to determine where the cancer originated. One example might be a CT scan of the chest to look for signs of Lung Cancer.
  • Collecting and testing a sample of abnormal tissue (biopsy): A Biopsy can be performed as part of an operation to remove the Brain tumor, or a Biopsy can be performed using a needle.

A stereotactic needle biopsy may be done for brain tumors in hard to reach areas or very sensitive areas within your brain that might be damaged by a more extensive operation. Your Neurosurgeon drills a small hole into your skull. A thin needle is then inserted through the hole. Tissue is removed using the needle, which is frequently guided by CT or MRI scanning.

The Biopsy sample is then viewed under a microscope to determine if it is cancerous or benign. This information is critical to establish a diagnosis and prognosis and, most importantly, in guiding treatment.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: American Public Health Association | American Society for Cell Biology (ASCB) | American Society for Experimental Neuro Therapeutics (ASENT) |  American Society for Neural Transplantation & Repair |  Association for Psychological Science |  National Association for Equal Opportunity in Higher Education (NAFEO) | Children's Brain Disease Foundation

Track 16:   Neuroradiology

Neuroradiology uses primary imaging modalities including computed tomography (CT) and magnetic resonance imaging (MRI) to focus on Endovascular or minimally invasive diagnosis and characterization of abnormalities of the Central Nervous System or head and neck lesions such as Tumors, Aneurysms, Vascular malformations, or Stroke. It involves different types of Imaging Studies like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) for characterization of various Neurological disorders.

Relevant Conferences: Neurology Conference | Neuroscience conferences | Neurology Congress |  28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5thWorld Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria; 5thInternational Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria; 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | American Society of Clinical Oncology | Georgian Society of Neurologists | American Brain Tumour Association | American Cancer Society |  Canadian Cancer Society

Track 17:   Neuroimmunology

The Immunotherapy treats the Immune system in Injury and repair during wide range of Neurological disorders, Inflammatory and Autoimmune Diseases of the Nervous system such as Multiple Sclerosis (MS) and Neuromyelitis Optical (NMO) and several Brain Tumor conditions. There were numerous Radiological studies to improve Diagnosis and treatment of these diseases. The main focus is to develop the so-called Neuroprotective (nerve cell protecting) treatment approaching and establishing Modern examination procedures such as MRI (Magnetic Resonance Imaging), OCT (Optical Coherence Tomography) and Motion Analysis.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | American Association of Neurological Surgeons (AANS) | Georgian Society of Neurologists

Track 18:   Neuroimaging

Neuroimaging is the Mapping of human Brain using functional Magnetic Resonance Imaging (fMRI). It determines how difference and change in Cerebral structure, complexly relates to Behavior and Cognition at Multiple levels of Analysis. It includes Multimodality imaging like CT, MRI, PET, to offer most precise information noninvasively, on type of the Tumor and grade; it also guides therapeutic choices and also assesses the effects of therapy

Neuroimaging development, testing, and implementation of advanced MRI and PET Imaging biomarkers for the characterization of Brain Tumor biology and response evaluation in Clinical trials able to detect the biological behaviour of Brain Tumor more accurately.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: American Public Health Association | American Society for Cell Biology (ASCB) | American Society for Experimental Neuro Therapeutics (ASENT) |  American Society for Neural Transplantation & Repair |  Association for Psychological Science |  National Association for Equal Opportunity in Higher Education (NAFEO)

Track 19:    Medical Treatment of Metastatic Cancer to the Nervous System

A Metastatic Cancer is one which has spread from the primary site of origin into different area of the body. That occurs in about one-fourth of all cancers that spread through the body.  Treatment for Metastatic Cancer aims to slow the growth or spread of the Cancer. Treatment depends on the type of cancer, where it started, the size and location of the Metastasis, and other factors.

The primary tumor may be found by examining tumor tissues from the brain. Tests may include; Cerebral Angiography, Mammogram, Chest x-ray, CT scans of the Chest, Abdomen, and Pelvis to find the original tumor site, MRI of the Brain, Lumbar puncture, EEG.

Relevant Conferences: Neurology Conference | Neuroscience conferences | Neurology Congress |  28th World Congress on Neurology and Therapeutics, February 28 – March 02, 2019 | Berlin, Germany; 7th International Conference on Brain Disorders and Therapeutics, September 19-20, 2019 Brussels, Belgium; 32nd European Neurology Congress, July 22-24, 2019 London, UK; 5thWorld Congress on Parkinsons & Huntington Disease, August 19-20, 2019 Vienna, Austria; 5thInternational Conference on Epilepsy & Treatment, August 19-20, 2019 Vienna, Austria; 23rdInternational Conference on Neurology & Neurophysiology March 18-19, 2019 Edinburgh, Scotland

Related Associations and Societies: American Public Health Association | American Society for Cell Biology (ASCB) | American Society for Experimental Neuro Therapeutics (ASENT) |  American Society for Neural Transplantation & Repair |  Association for Psychological Science |  National Association for Equal Opportunity in Higher Education (NAFEO)

Track 20:   Treatment of cancer related complications

Occurrence of Cancer related complications are seen during Chemotherapy because the dividing blood cells in bone marrow are also prone to damage from medications used in treatment also many of these side effects can be attributed to low blood counts. In rare cases, some Chemotherapy drugs can cause Heart damage or trigger another cancer such as Leukaemia. Some complications seen are

  •         Infection
  •         Fatigue
  •         Bruising
  •         Bleeding
  •         Sleep disturbances

Preventive measures should start before cancer therapy begins, reducing the occurrence of further problems brought about by different treatment modalities.

Relevant Conferences: Neurology and Psychiatric Meetings | Mental health and Neuroscience summit | Psychology and Neurological disorders conferences | 28th World Congress on Neurology and Therapeutics | 7th Global Annual Meeting on Neurology and NeuroSurgery | 2nd International Conference on Epilepsy and Treatment

Related Associations and Societies: Cyprus Neurological Society | Czech Society of Neurology | Danish Neurological Society | Estonian Society of Neurologists & Neurosurgeons | Finnish Neurological Association | American Association of Neurological Surgeons (AANS) | Georgian Society of Neurologists

The Conference Neuro-oncology 2019

We are happy to welcome you to the official website of 5th International Conference on Neuro-Oncology and Brain Tumor (Neuro-Oncology 2019) during August 14-15, 2019 Tokyo,Japan with the theme of "Future challenges and the latest Impact Factor for Neuro-Oncology and Brain Tumor" which covers wide range of critically important sessions. It’s a platform to bring all the neurooncologists and Neuroscientists together to share their experiences it’s the amalgam of scientific research as well as innovative ideas.

Overview of Neuro-oncology and Brain tumour:

An important area of clinical Neuro-Oncology and Brain Tumour that is increasingly relevant as survivorship increases and as patients experience potential morbidities associated with new therapies. Neuro-Oncology is the study of Brain and Spinal cord neoplasms, many of which are   (at least eventually) very dangerous and life-threatening (Astrocytoma, Glioma, Glioblastoma multiforme, Ependymoma, Pontine Glioma, and Brain stem tumors are among the many examples of these). Among the Malignant Brain cancers, Gliomas of the brainstem and pons, Glioblastoma multiform, and high-grade (highly anaplastic) Astrocytoma are among the worst.

Geographically market is segmented into Europe, North America, Latin America, Asia pacific, and Middle East and Africa. According to market study, Market Value for Neuro Oncology (i.e. on Brain Cancer and CNS Tumors) will be more than double to $ 623 Million by 2020. A major part of research is going on the top Universities on across the globe. Many companies are associated with various diagnostic instruments and other therapeutics. Besides this various societies and research labs are also associated in this research field.

Conference Highlights:

Neuro-Oncology

Neurological Disorders

Brain Tumor

Advancements in Neuro-Oncology

Neoplasms

Neurosurgical Oncology

Metastatic Cancer

Advancements in Brain Tumor

Neuro Pharmacology

Brain Tumor Diagnosis

Gangliocytoma

Neuroradiology

Choroid Plexus Tumor

Immunotherapy

Brainstem Glioma

Neuroimaging

Neuropsychology 

Medical Treatment of Metastatic Cancer to the Nervous System

Para Neoplastic Neurological Syndrome

Treatment of cancer related complications

Who Should Attend?

  • Directors
  • Head of Department
  • Professors
  • Industrial Researchers
  • Neuro-oncologist
  • Radiation Oncologists
  • Oncologists
  • Neuropediatricians
  • Neurophysiologists
  • Neurosurgeons
  • Neurologist
  • Neuroradiologist
  • Neuro-Pathologists
  • Rehabilitation Specialists
  • Nurses
  • Neuroscience Researchers and Students from academia in the research of Neuro-oncology, Neurooncology Associations, Brain tumour societies

Target Audience:

Academia: 65%

Industry: 25%

Others: 10%

Why to attend?

5th International Conference on Neuro-Oncology and Brain Tumor tends to bring together worldwide distinguished academics in the field of Neuro-oncologist, Oncologist, Radiation Oncologist, Medical Oncologists, Neuropharmacology, Neurology, Neuropediatricians, Pediatric Oncologists, Neurosurgeons, Neurophysiologists,  Neuroscience  Brain researchers, Public Health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the art Research and Technologies and to bring discoveries of cancer to Patients. Attending International conference is for the Professional Development and to understand the current state of research and the challenges to future discovery.

The aim of the Conference is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology.

For more details please visit: https://neurooncology.conferenceseries.com/

 Who should sponsor/exhibit:

  • Basic and Translational Laboratory Researchers       
  • Hospitals
  • Educational Institutes
  • Research Centers
  • Charitable Foundations focused on funding research, advocating for and supporting the needs

Benefits of attending:

  • Networking Opportunities, Grow Your Professional Network
  • Build Your Knowledge Base
  • Expand Your Resources
  • Meet Experts & Influencers Face to Face
  • Learning in a New Space
  • Break Out of Your Comfort Zone
  • New Tips & Tactics
  • Greater Focus
  • Top Industries Representation
  • Abstracts will be published in the conference souvenir and respective International journals
  • Each Abstract will receive unique (DOI) Number provided by Cross Ref
  • Website visibility to more than 35K visitors in less than 6 months
  •  Laudable talks by the top-notch of the Global Scientific Community
  • The Serendipity of the Random Workshop
  • Will be felicitated with International Organizing Committee Member (IOCM)
  • Remarkable Awards and Global Recognition to meritorious Researchers

Neuro-oncology 2019 welcomes attendees, presenters, and exhibitors from all over the world to Tokyo, Japan. We are delighted to invite you all to attend and register for the 5th International Conference on Neuro-Oncology and Brain Tumor which is going to be held during August 14-15, 2019 Tokyo,Japan.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Neuro-oncology 2019, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Neuro-oncology 2019 organizing committee look forward to meeting you in Seoul, South Korea.

For more details please visit- https://neurooncology.conferenceseries.com/

Importance and Scope:

5th International Conference on Neuro-Oncology and Brain Tumor is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Neuroscience.

Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Neuroscience and its allied areas.

Why tokyo?

Tokyo, officially the Tokyo Special Metropolitan City, is the capital and largest metropolis of Japan. Tokyo is the hub of Cancer Institutes and center for Cancer Research. In recent years, the number of international students for Cancer Research at Japan universities has risen rapidly.

Conference Highlights:

  • Neuro-Oncology

  • Genomics & Molecular Neurology

  • Neurological Disorders

  • Geriatrics Neurology

  • Neuro-Oncology & Tumours

  • Neuroimaging & Neuroradiology

  • Brain Mapping & Biomarkers

  • Neuro-endocrinal Immunology

  • Neurogenesis and Neuroregeneration

  • Advancements in Brain Tumor

  • Neurosurgery and Spine Surgery

  • Neurodegenerative Disorders

  • Computational Neuroscience

  • Cognitive and Behavioral Neuroscience

  • Clinical Neurology and Nursing

  • Neuro-pharmaceutics and Neurophysiology

  • Neuro-therapeutics & Case Studies

  • Para Neoplastic Neurological Syndrome

  • Treatment of cancer related complications

  • Medical Treatment of Metastatic Cancer to the Nervous System

  • Brain Tumor Diagnosis

Why to attend???

Neuro-oncology and Therapeutics is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Brain disorders.

A Unique Opportunity for Advertisers and Sponsors at this International event:

https://neurooncology.conferenceseries.com/sponsors.php

 Major Associations around the Globe

  • Neuropathy Association

  • The brain & behaviour research foundation

  • Alzheimer's Association

  • American Academy of Neurology

  • European Neurological Societies

  • World Federation of Neurology

  • Spanish Society of Neurology

  • Major Neurological Associations in Italy

  • Hilarescere Foundation in Italy

  • Italian MS society in Italy   

  • Southern Clinical Neurological Society

  • ESNR European Society of Neuroradiology

  • Vision sciences society

Around 20 associations of Neurology are there in Germany

  • German Neurological Society

  • Society Of Neuroscience

  • European Paediatric Neurology Society

  • German Society Of Neurosurgery

  • Munich Canter Of Neuroscience

  • International Society Of Neurochemistry

  • German Association For Psychiatry, Psychotherapy And Psychosomatics

  • German Neurological Society

  • German Stroke Society

  • European Paediatric Neurology Society

  • Einstein Center for Neurosciences (ECN)

  • Bernstein Center for Computational Neuroscience

  • The World Society for Stereotactic and Functional Neurosurgery

  • Bernstein Center for Computational Neuroscience

  • Society for Neuroeconomics

  • European Neurological Society

  • The European Association Of Neurosurgicalsocieties (EANS)

Major Cleveland Clinics and Hospitals for Neuro-Oncology & Neurosurgery across the globe:

  • Neurological Institute at Cleveland Clinic Abu Dhabi

  • The Gerry & Nancy Pencer Brain Tumor Centre Toronto, Canada

  • Brain Tumour Foundation of Canada

  • Sunnybrook Health Sciences Centre

  • Municipal Nerve Hospital, Japan

  • Naval Hospital Yokosuka, Japan

  • St. Luke's International Hospital, Japan

  • National Hospital for Neurology and Neurosurgery, Queen Square

  • Walton Centre, Liverpool

  • Royal Hospital for Neuro-disability, Putney

  • London Bridge Hospital

  • St George's Hospital, UK

  • King's College Hospital, UK

  • Clinic NeuroVita, Russia

  • Beacon Hospital, Malaysia

List of cancer drugs approved by the FDA for use in brain tumors

  • Gliolan

  • TRXE-009

  • Temozolomide

  • Afinitor (Everolimus)

  • Afinitor Disperz (Everolimus)

  • Avastin (Bevacizumab)

  • Becenum (Carmustine)

  • Bevacizumab

  • BiCNU (Carmustine)

  • Carmubris (Carmustine)

  • Carmustine

  • Carmustine Implant

  • CeeNu (Lomustine)

  • Everolimus

  • Gliadel (Carmustine Implant)

  • Gliadel wafer (Carmustine Implant)

  • Lomustine

  • Methazolastone (Temozolomide)

  • Temodar (Temozolomide)

Target Audience:

Directors, Neurologist, Neurosurgeons, Psychiatrist, head of department, Professors and Students from Academia in the research of Neuroscience.

Target Audience:

Academia 60%

Industry   30%

Others       10%

Top universities globally working in the field of Neuroscience

  • Dalhousie University

  • Leiden University- Neither land

  • Temple University USA

  • University Oklahoma

  • Boston Coll USA

  • Florida International University

  • University California – Davis

  • University Sheffield

  • University Manchester

  • University of Nottingham

  • Cardiff University

  •  University of Toronto – Canada

A major part of research is going on the top Universities on Neuro-Oncology across the globe:

  • Stanford University in California

  • Columbia University Medical Center

  • UC San Diego

  • CERN Medical Research

  • University of Wolver Hampton

  • University of Chicago

  • University Hospital Heidelberg

  • University of Michigan Health System

  • Duke University in Durham, NC

  • Washington University in St. Louis, MO

  • University of California

  • Harvard Medical School

  • UCSF School of Medicine

  • Perelman School of Medicine

  • Yale School of Medicine

  • Maryland School of Medicine

  • Warren Alpert Medical School

  • University of Virginia.

  • University of Rochester Medical Centre

Major Associations and Societies of Neuro-Oncology and Brain Tumor Worldwide:

  • Asian Society for Neuro-Oncology        

  • Australian Oncology Social Work Inc

  • SNO Society for Neuro-Oncology

  • Royal Society of London

  • American Society of Clinical Oncology

  • American Academy of Neurology

  • The brain & behavior research foundation

  • World Federation of Neurology

  • ESNR European Society of Neuroradiology

  • Vision sciences society

  • American Brain Tumour Association

  • American Cancer Society

  • European Scientific Society

  • Canadian Cancer Society

  • National Brain Tumor Society

  • The Neuro Association

  • British neuroscience association

  • British Neuro-oncology Society

  • European Scientific Society

  • Canadian Cancer Society

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 14-15, 2019
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2
Poster Opportunity Closed Click Here to View